PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells
Authors:
Open Access
- 18 November 2008
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (12) , 2044-2053
Abstract
Brain tumour stem cells (BTSCs) are a small population of cells that has self-renewal, transplantation, multidrug resistance and recurrence properties, thus remain novel therapeutic target for brain tumour. Recent studies have shown that peroxisome proliferator-activated receptor gamma (PPARγ) agonists induce growth arrest and apoptosis in glioblastoma cells, but their effects on BTSCs are largely unknown. In this study, we generated gliospheres with more than 50% CD133+ BTSC by culturing U87MG and T98G human glioblastoma cells with epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF). In vitro treatment with PPARγ agonist, 15-Deoxy-Δ12,14-Prostaglandin J2 (15d-PGJ2) or all-trans retinoic acid resulted in a reversible inhibition of gliosphere formation in culture. Peroxisome proliferator-activated receptor gamma agonists inhibited the proliferation and expansion of glioma and gliosphere cells in a dose-dependent manner. Peroxisome proliferator-activated receptor gamma agonists also induced cell cycle arrest and apoptosis in association with the inhibition of EGF/bFGF signalling through Tyk2-Stat3 pathway and expression of PPARγ in gliosphere cells. These findings demonstrate that PPARγ agonists regulate growth and expansion of BTSCs and extend their use to target BTSCs in the treatment of brain tumour.Keywords
This publication has 51 references indexed in Scilit:
- Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive PhenotypeMolecular Cancer Research, 2008
- The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cellsMolecular and Cellular Endocrinology, 2007
- Targeting brain-tumor stem cellsNature Biotechnology, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cellsBritish Journal of Cancer, 2006
- Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosisNature, 2003
- Embryonic stem cell-derived neurogenesisCell and tissue research, 2001
- Fibrolast growth factors in the nervous systemJournal of Neurobiology, 1994
- Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomasJournal of Neuro-Oncology, 1994
- Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomasJournal of Neurosurgery, 1992